Related Experiment Videos
The Global TB Drug Facility: innovative global procurement.
J Kumaresan1, I Smith, V Arnold
1Stop TB Partnership Secretariat, World Health Organization, Geneva, Switzerland. JKumaresan@trachoma.org
Summary
The Global TB Drug Facility (GDF) improves access to quality tuberculosis drugs for millions. This initiative uses innovative supply chain methods to help countries meet global TB control targets.
Area of Science:
- Global Health
- Pharmaceutical Procurement
- Tuberculosis Control
Background:
- Tuberculosis remains a significant global health challenge.
- Access to high-quality tuberculosis drugs is crucial for effective treatment and control.
- Existing procurement mechanisms may not adequately meet diverse country needs.
Purpose of the Study:
- To describe the operational procedures and experiences of the Global TB Drug Facility (GDF).
- To highlight the GDF's innovative approach to drug supply and management.
- To assess the GDF's achievements in improving tuberculosis drug access and affordability.
Main Methods:
- The GDF links drug demand to supply and monitoring, utilizing partners for service delivery.
- Innovative product packaging simplifies drug management.
- Grant allocation is linked to tuberculosis program performance.
Main Results:
- The GDF has supported 46 countries and NGOs since its launch in 2001.
- Key achievements include a flexible supply system, reduced drug prices, and product standardization.
- The GDF has facilitated DOTS expansion and collaboration among partners.
Conclusions:
- The GDF's flexible and innovative model effectively increases access to quality tuberculosis drugs.
- The GDF's experience offers a transferable model for global procurement of essential medicines for other diseases.
- Future expansion may include second-line drugs, diagnostics, and support for similar initiatives.